Literature DB >> 20887837

The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgery.

Coen L Klos1, Paul C Shellito, David W Rattner, Richard A Hodin, James C Cusack, Liliana Bordeianou, Patricia Sylla, Theodore S Hong, Lawrence Blaszkowsky, Davis P Ryan, Gregory Y Lauwers, Yuchiao Chang, David L Berger.   

Abstract

BACKGROUND: Neoadjuvant therapy may affect the prognostic impact of total lymph node harvests and lymph node positivity after surgery for rectal cancer.
METHODS: We performed a retrospective review of 390 consecutive patients with histologically confirmed rectal cancer. Postoperative follow-up evaluation and survival were confirmed via medical record review. The impacts of lymph node positivity and total lymph node harvest on survival and recurrence are reflected as proportional hazard ratios (HRs).
RESULTS: A total of 221 patients underwent neoadjuvant therapy, of whom 75 had positive nodes. Node-positive patients showed a significantly shorter survival time (HR, 2.89; P = .002) and time to local recurrence (HR, 6.36; P = .031) compared with patients without positive nodes. Survival and recurrence were not significantly different between patients with a total harvest of fewer than 12 nodes and patients with a higher lymph node harvest.
CONCLUSIONS: After neoadjuvant treatment and total mesorectal excision, lymph node positivity is associated with significantly shorter survival and time to local recurrence in rectal cancer patients, whereas absolute total lymph node harvests likely have little impact on prognosis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20887837     DOI: 10.1016/j.amjsurg.2010.03.013

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  12 in total

Review 1.  Multidisciplinary management in rectal cancer.

Authors:  Asunción Hervás Morón; María Luisa García de Paredes; Eduardo Lobo Martínez
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

Review 2.  Adjuvant chemotherapy for rectal cancer: Is it needed?

Authors:  Kristijonas Milinis; Michael Thornton; Amir Montazeri; Paul S Rooney
Journal:  World J Clin Oncol       Date:  2015-12-10

3.  Transanal TAMIS total mesorectal excision (TME)--a work in progress.

Authors:  S D Wexner; M Berho
Journal:  Tech Coloproctol       Date:  2014-03-29       Impact factor: 3.781

4.  Induction FOLFOX followed by preoperative hyperfractionated radiotherapy plus bolus 5-fluorouracil in locally advanced rectal carcinoma: single arm phase I-II study.

Authors:  Engy M Aboelnaga; Mohamed A Daoud; Entesar I Eladl; Amir M Zaid
Journal:  Med Oncol       Date:  2015-03-07       Impact factor: 3.064

5.  What Is the Minimum Number of Examined Lymph Nodes After Neoadjuvant Therapy in Rectal Cancer?

Authors:  Peng Gao; Yongxi Song; Yuchong Yang; Shan Zhao; Yu Sun; Jingxu Sun; Xiaowan Chen; Zhenning Wang
Journal:  J Gastrointest Surg       Date:  2018-02-21       Impact factor: 3.452

6.  Lymph node retrieval after preoperative chemoradiotherapy for rectal cancer.

Authors:  Daniel C Damin; Mário A Rosito; Paulo C Contu; Cláudio Tarta; Paulo R Ferreira; Lucia M Kliemann; Gilberto Schwartsmann
Journal:  J Gastrointest Surg       Date:  2012-05-23       Impact factor: 3.452

7.  A retrospective study on the impact of the number of resected lymph nodes on the survival outcome of stage IV rectal cancer patients after preoperative therapy.

Authors:  Kexiang Xi; Hui Yu; Kexing Xi
Journal:  J Gastrointest Oncol       Date:  2020-10

8.  The assessment of risk factors for long-term survival outcome in ypN0 patients with rectal cancer after neoadjuvant therapy and radical anterior resection.

Authors:  Marcin Zeman; Marek Czarnecki; Ewa Chmielik; Adam Idasiak; Władysław Skałba; Mirosław Strączyński; Piotr J Paul; Agnieszka Czarniecka
Journal:  World J Surg Oncol       Date:  2021-05-21       Impact factor: 2.754

9.  Lymphangiogenesis in regional lymph nodes is an independent prognostic marker in rectal cancer patients after neoadjuvant treatment.

Authors:  Christiane Jakob; Daniela E Aust; Birgit Liebscher; Gustavo B Baretton; Kaustubh Datta; Michael H Muders
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

10.  Influence of tumor location on short- and long-term outcomes after laparoscopic surgery for rectal cancer: a propensity score matched cohort study.

Authors:  Hong Yang; Zhendan Yao; Ming Cui; Jiadi Xing; Chenghai Zhang; Nan Zhang; Maoxing Liu; Kai Xu; Fei Tan; Xiangqian Su
Journal:  BMC Cancer       Date:  2020-08-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.